Tag: Court

Posted on

AstraZeneca’s patent on asthma drug invalidated by U.S. court – Business Insider


Business Insider

AstraZeneca's patent on asthma drug invalidated by U.S. court
Business Insider
NEW YORK (Reuters) – A U.S. federal judge ruled late on Friday that AstraZeneca PLC's patent on its Pulmicort Repsules treatment for asthma was invalid, opening up the market to a second, cheaper generic version. Actavis Plc said that the U.S. District …
AstraZeneca plc (ADR) Patent On Asthma Drug Declared Invalid By US CourtBidness ETC
AstraZeneca loses its US patent rights for asthma drug Pulmicort RespulesCITY A.M.

all 37 news articles »

View full post on asthma – Google News

Posted on

AstraZeneca’s patent on asthma drug invalidated by US court – Reuters


Reuters

AstraZeneca's patent on asthma drug invalidated by US court
Reuters
NEW YORK (Reuters) – A U.S. federal judge ruled late on Friday that AstraZeneca PLC's patent on its Pulmicort Repsules treatment for asthma was invalid, opening up the market to a second, cheaper generic version. Actavis Plc said that the U.S. District …
Actavis launches Pulmicort Respules generic on AZ legal lossPharmaTimes

all 7 news articles »

View full post on asthma – Google News

Posted on

AstraZeneca’s patent on asthma drug invalidated by US court – Yahoo News


euronews

AstraZeneca's patent on asthma drug invalidated by US court
Yahoo News
NEW YORK (Reuters) – A U.S. federal judge ruled late on Friday that AstraZeneca PLC's patent on its Pulmicort Repsules treatment for asthma was invalid, opening up the market to a second, cheaper generic version. Actavis Plc said that the U.S. District …
Actavis launches Pulmicort Respules generic on AZ legal lossPharmaTimes

all 2 news articles »

View full post on asthma – Google News

Posted on

Appeals court rejects challenge to sulfur dioxide rule designed to protect … – Washington Post

Appeals court rejects challenge to sulfur dioxide rule designed to protect …
Washington Post
WASHINGTON — A federal appeals court has rejected a challenge to a tough new clean air requirement limiting sulfur dioxide emissions. The Environmental Protection Agency regulation is designed to prevent people with asthma from exposure to short-term …
EPA Sulfur Dioxide Rules Upheld by US Court of AppealsBusinessweek
Court Upholds EPA's Stricter NO2 StandardsCourthouse News Service

all 2 news articles »

View full post on asthma – Google News

Posted on

Mylan to challenge court decision over generic asthma, COPD drug – Drug Store News

Mylan to challenge court decision over generic asthma, COPD drug
Drug Store News
… in the US District Court for the District of Delaware when the latter sought to market a generic version of Sunovion's Xopenex (levalbuterol hydrochloride) inhalation solution, a drug for asthma and chronic obstructive pulmonary disease.
Mylan to fight $18M patent infringement rulingPittsburgh Business Times

all 4 news articles »

View full post on asthma – Google News

Posted on

Patients’ inhaler switch hotly debated in court – New Zealand Doctor Online

Patients' inhaler switch hotly debated in court
New Zealand Doctor Online
The Symbicort inhaler's ability to control, prevent and relieve asthma for some patients without the need for a separate reliever has been argued as meriting full funding by Pharmac. The rapid action of the Symbicort Turbuhaler makes a critical …
Pharmac taken to court over asthma subsidyRadio New Zealand

all 3 news articles »

View full post on asthma – Google News

Posted on

Pharmac taken to court over asthma subsidy – Radio New Zealand

Pharmac taken to court over asthma subsidy
Radio New Zealand
The High Court in Wellington has begun hearing a case that could affect the asthma inhalers used by about 20000 people. Drug firm Astrazeneca is challenging plans by the Government's drug-buying agency Pharmac to reduce the subsidy on combination …
AstraZeneca and Pharmac butt heads in High CourtNew Zealand Doctor Online

all 5 news articles »

View full post on asthma – Google News